Log in to search using one of your social media accounts:

 

J & J Vision closes TearScience buyout
Johnson & Johnson‘s (NYSE:JNJ) Vision business said today that it closed its acquisition of ophthalmological medical device maker TearScience for an undisclosed amount. Resarch Triangle Park, N.C.-based TearScience produces devices focused on treating meibomian gland dysfunction, a leading underlying cause of dry eye disease, Johnson & Johnson said. The company won FDA clearance for its office-based treatment of meibomian glands and treating MGD, with its devices available in the US and global markets. “Dry eye is too often the culprit of why patients drop out of contact lenses or why they may...
Source: Mass Device - September 6, 2017 Category: Medical Devices Authors: Brad Perriello Tags: Mergers & Acquisitions Optical/Ophthalmic Wall Street Beat johnsonandjohnson TearScience Source Type: news

End of postcode lottery for cataracts treatment
Helen Heraty, who runs a boutique hotel in York, was told that she could only have cataract surgery on one eye – despite being virtually blind. (Source: the Mail online | Health)
Source: the Mail online | Health - August 26, 2017 Category: Consumer Health News Source Type: news

Reforms set to improve life for sight impaired
Department of Health introduces changes to Certificate of Vision Impairment forms Related items fromOnMedica STPs can help CCGs deliver eye care at scale Eye problems Eye problems: the eyelids Ongoing concerns that cataract surgery being cut to save cash (Source: OnMedica Latest News)
Source: OnMedica Latest News - August 22, 2017 Category: UK Health Source Type: news

MassDevice.com +5 | The top 5 medtech stories for August 21, 2017
Say hello to MassDevice +5, a bite-sized view of the top five medtech stories of the day. This feature of MassDevice.com’s coverage highlights our 5 biggest and most influential stories from the day’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry. Get this in your inbox everyday by subscribing to our newsletters.   5. Medical device product development: pitfalls you need to avoid Managing your medical device product development project can be a daunting task. There are regulations and paperwork to manage, along with expectations such as dead...
Source: Mass Device - August 21, 2017 Category: Medical Devices Authors: MassDevice Tags: News Well Plus 5 Source Type: news

Carl Zeiss acquires cataract surgery planning software dev Veracity Innovations
Carl Zeiss Meditec (ETR:AFX) said today it is acquiring cloud-based ophthalmological tech developer Veracity Innovations for an undisclosed amount. Veracity Innovations developed and produces a cloud-based surgical planning platform for cataract surgeries, covering initial planning, management and analysis of the procedures. The system is designed to interface directly with multiple electronic medical records and diagnostic devices, covering patients from initial consultation through post-operation, Carl Zeiss said. “Digital technology is fundamentally changing our world and has a major impact in healthcare. Eff...
Source: Mass Device - August 21, 2017 Category: Medical Devices Authors: Fink Densford Tags: Mergers & Acquisitions Optical/Ophthalmic Software / IT Carl Zeiss Meditec veracityinnovations Source Type: news

GPs must consult panel to sending patients to hospital
The controversial scheme in the north east of England covers all non-urgent referrals – including requests for hip and knee surgery, cataract removal as well as x-rays and scans. (Source: the Mail online | Health)
Source: the Mail online | Health - August 12, 2017 Category: Consumer Health News Source Type: news

WEIRD: Cataract surgery patient has 27 contact lenses removed from her EYE
(Natural News) A case study published on the British Medical Journal website revealed that a 67-year-old British woman, who was scheduled for cataract surgery in November 2016 due to eye discomfort and dryness, actually had 27 contact lenses jammed in one of her eyes. The doctors initially found a bluish mass of 17 disposable contact lenses in... (Source: NaturalNews.com)
Source: NaturalNews.com - July 22, 2017 Category: Consumer Health News Source Type: news

British surgeons find mass of contact lenses in patient's eye
Doctors at a hospital in England were surprised to find a mass of contact lenses in a 67-year-old patient's eye, during what should have been routine cataract surgery. (Source: CBC | Health)
Source: CBC | Health - July 18, 2017 Category: Consumer Health News Tags: News/Health Source Type: news

British doctors find mass of contact lenses under patient's eyelid
Doctors at a hospital in England were surprised to find a mass of contact lenses under a 67-year-old patient's eyelid, during what should have been routine cataract surgery. (Source: CBC | Health)
Source: CBC | Health - July 18, 2017 Category: Consumer Health News Tags: News/Health Source Type: news

Surgeon removes 27 contact lenses from woman's eye during cataract surgery
CONTACT LENSES must be used with a degree of caution, as one woman from the West Midlands has discovered after 27 were removed from one eye during routine cataract surgery (Source: Daily Express - Health)
Source: Daily Express - Health - July 18, 2017 Category: Consumer Health News Source Type: news

Doctors find 27 contact lenses in woman's eye
A 67-year-old woman scheduled for routine cataract surgery in November thought it was just dry eye and old age causing her discomfort, she told her surgeons. (Source: CNN.com - Health)
Source: CNN.com - Health - July 17, 2017 Category: Consumer Health News Source Type: news

WARNING: Surgeons remove 27 contact lenses from woman's eye during cataract surgery
CONTACT LENSES must be used with a degree of caution, as one woman from the West Midlands has discovered after 27 were removed from one eye during routine cataract surgery (Source: Daily Express - Health)
Source: Daily Express - Health - July 17, 2017 Category: Consumer Health News Source Type: news

Beaver-Visitec buys ophthalmic tech dev Vitreq
Beaver-Visitec said today it acquired ophthalmic tech company Vitreq for an undisclosed amount. Netherlands-based Vitreq develops and manufactures ophthalmic devices, with a specific focus on vitreoretinal surgery. The company’s portfolio includes a number of minimally-invasive instruments designed for use in ophthalmological surgical settings, Waltham, Mass.-based Beaver-Visitec said. “At Vitreq, it’s our mission to develop reliable, safe, and sophisticated tools that provide surgeons with the support and innovation necessary to perform at the highest levels. In BVI, we have found a partner that is ...
Source: Mass Device - July 12, 2017 Category: Medical Devices Authors: Fink Densford Tags: Business/Financial News Mergers & Acquisitions Optical/Ophthalmic Beaver-Visitec Vitreq Source Type: news

Patients forced to beg NHS to fund cataract or hip surgery
Patients are being forced to plead with the NHS for hip and cataract surgeries. Demand for the operations has surged. They were previously routinely available on the NHS. (Source: the Mail online | Health)
Source: the Mail online | Health - July 4, 2017 Category: Consumer Health News Source Type: news

NHS struck by new operations crisis as patients wait for knee, hip and cataract surgery
PATIENTS waiting for crucial knee, hip and cataract operations are facing long delays, a damning report claims. (Source: Daily Express - Health)
Source: Daily Express - Health - July 4, 2017 Category: Consumer Health News Source Type: news

NHS 'rationing leaves patients in pain'
Doctors have to make special appeals for vital treatments such as hip operations and cataract surgery. (Source: BBC News | Health | UK Edition)
Source: BBC News | Health | UK Edition - July 4, 2017 Category: Consumer Health News Source Type: news

Icon Bioscience touts FDA NDA submission for Dexycu
Icon Bioscience said today that the FDA accepted the company’s submitted new drug application for its Dexycu drug designed to be used as an anti-inflammatory following cataract surgery. The Newark, Calif.-based company’s Dexycu utilizes the company’s Verisome novel drug delivery system designed to treat ophthalmic diseases and slowly release the drug while the Verisome system simultaneously degrades, according to the company’s site. Read the whole story at our sister site, Drug Delivery Business The post Icon Bioscience touts FDA NDA submission for Dexycu appeared first on MassDevice. (Source: Mass Device)
Source: Mass Device - June 26, 2017 Category: Medical Devices Authors: Fink Densford Tags: Drug-Device Combinations Food & Drug Administration (FDA) iconbioscience Source Type: news

Fluoroquinolones Less Effective Against Endophthalmitis Pathogen Fluoroquinolones Less Effective Against Endophthalmitis Pathogen
An in vitro case series suggests that coagulase-negative Staphylococcus (CoNS), the most common cause of endophthalmitis after cataract surgery, is becoming less susceptible to fluoroquinolones, according to Florida-based researchers.Reuters Health Information (Source: Medscape Ophthalmology Headlines)
Source: Medscape Ophthalmology Headlines - June 26, 2017 Category: Opthalmology Tags: Ophthalmology News Source Type: news

Pulaski County’s Most Expensive Home Sales of 2016
Sales of luxury homes in Pulaski County jumped in 2016 to a number not seen since Arkansas Business began tracking them in 2004. Last year, 29 homes sold for $1 million or more, up from 20 in 2015. Arkansas Business has been keeping statistics on high-end sales since 2004, when 29 million-dollar homes were sold. Sales hit a low of 13 in 2012. This year, strong sales should continue, Jon Underhill predicted in an email to Arkansas Business last week. Underhill sells upscale home through his agency, Jon Underhill Real Estate of Little Rock. “The economy and the stock market are both doing well, and that bodes well for ...
Source: Arkansas Business - Health Care - June 19, 2017 Category: American Health Source Type: news

ASCRS 2017: Refining Cataract and Refractive Surgery ASCRS 2017: Refining Cataract and Refractive Surgery
From illuminating risk factors for post-LASIK failure to the promising SMILE procedure, it was a meeting of status quo challenging data.Medscape Ophthalmology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - June 16, 2017 Category: Consumer Health News Tags: Ophthalmology Commentary Source Type: news

Does Your Pet Need an Eye Doctor?
Veterinarians specialized in vision problems are few, but some conditions ailing dogs and other animals can be treated. (Source: NYT Health)
Source: NYT Health - June 6, 2017 Category: Consumer Health News Authors: SUSAN JENKS Tags: Eyes and Eyesight Dogs Cats Cataracts Genetics and Heredity Foxes Veterinary Medicine Surgery and Surgeons Transplants Pets Glaucoma Corneas Blindness Doctors Genetic Engineering Source Type: news

Seychelles: Over 100 Patients Restore Fading Eyesight in Seychelles Eye Camp
[Seychelles News Agency] Elderly Seychellois citizens have this week walked out of the Seychelles Hospital with better vision following a four-day cataract-removal eye camp. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - June 1, 2017 Category: African Health Source Type: news

Namibia: 150 Have Eyesight Restored
[Namibian] Dozens of elderly people of the //Karas, Hardap and Omaheke regions were all smiles after undergoing free cataract surgery at the Keetmanshoop State Hospital over the last few days. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - May 26, 2017 Category: African Health Source Type: news

Diabetic Macular Edema Rates Increase After Cataract Surgery Diabetic Macular Edema Rates Increase After Cataract Surgery
The rates of treatment-requiring diabetic macular edema (DME) increase sharply in the year after cataract surgery, according to new findings from the U.K.Reuters Health Information (Source: Medscape Ophthalmology Headlines)
Source: Medscape Ophthalmology Headlines - May 25, 2017 Category: Opthalmology Tags: Ophthalmology News Source Type: news

LivaNova snags former J & J exec Huston as CFO | Personnel Moves, May 24, 2017
LivaNova (NSDQ:LIVN) said last week that it picked up former Johnson & Johnson medical device group chief financial officer Thad Huston as its new CFO, effective May 20. Huston will replace former CFO Vivid Sehgal, who coordinated with Huston during the transition. Huston spent more than 25 years with Johnson & Johnson, and held various positions, including prez of its Xian-Janssen Pharmaceuticals division in China, finance VP and CFO & COO for its pharmaceutical R&D and finance VP and CFO for its Ortho-McNeil Pharma division. “I am eager to join the exceptional team at LivaNova. We share a passi...
Source: Mass Device - May 24, 2017 Category: Medical Devices Authors: Fink Densford Tags: Business/Financial News Alcon Brainlab Cardiovascular Systems Inc. Fortimedix LivaNova Nativis Novartis sightlife Stimwave Technologies Teleflex Vuzix Source Type: news

Med device, drug delivery companies join J & J ’ s Toronto JLABS incubator
Johnson & Johnson (NYSE:JNJ) said today it has added 24 companies, including those in the medical device and drug delivery fields, to its JLABS incubator facility in Toronto, Canada. The facilities in Toronto now host over 40 companies, according to Johnson & Johnson, all of which are provided with lab space and offices, modular lab suites and access to scientific, industry and capital funding experts. “Our goal is to support early stage innovators with the resources and network needed to grow, and as evident by the 40 companies that reside within JLABS @ Toronto, we are already accomplishing what we set...
Source: Mass Device - May 11, 2017 Category: Medical Devices Authors: Fink Densford Tags: Business/Financial News Johnson & Johnson Source Type: news

Study: pSivida ’s Durasert lessens recurrence of uveitis through 12 months
pSivida (NSDQ:PSDV) touted 1-year follow-up data yesterday for the company’s Durasert 3-year treatment of posterior segment uveitis. The data, which was presented at the Association for Research in Vision and Ophthalmology annual meeting, is from pSivida’s 1st phase III trial. The data showed that the 3-year uveitis implant significantly reduced the recurrence of posterior segment uveitis through 12 months – 27.6% of patients treated with Durasert had a recurrence, compared to 85.7% of patients in the sham group. In phakic patients, 33.3% in the Durasert group required a cataract surgery in the year-...
Source: Mass Device - May 9, 2017 Category: Medical Devices Authors: Sarah Faulkner Tags: Clinical Trials Drug-Device Combinations Implants Optical/Ophthalmic Wall Street Beat pSivida Corp. Source Type: news

Nepafenac to Prevent Macular Edema in Diabetic Retinopathy Nepafenac to Prevent Macular Edema in Diabetic Retinopathy
A new study examines the protective effect of nepafenac against the development of macular edema after cataract surgery among patients with diabetic retinopathy.The British Journal of Ophthalmology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - May 9, 2017 Category: Consumer Health News Tags: Ophthalmology Journal Article Source Type: news

Visionary Ventures raises 1st $30m fund for ophthalmic companies
Orange County, Calif.-based ophthalmology Visionary Venture Fund and life sciences accelerator OCTANe said today they closed the fund’s 1st round of financing, raising $30 million. The groups said that the fund will be invested in approximately 12 opthalmology companies over the next 18 months. “Southern California’s ophthalmology companies are leading the global ophthalmology industry and we anticipate that the ecosystem here will continue to thrive. The concentration of ophthalmology innovation here is a testament to the region’s strong innovation at leading universities, healthcare institutions a...
Source: Mass Device - May 2, 2017 Category: Medical Equipment Authors: Fink Densford Tags: Business/Financial News Optical/Ophthalmic OCTANe Source Type: news

Kala touts Phase III data for nanoparticle ophthalmic suspension
Kala Pharmaceuticals touted data today from a Phase III trial of its nanoparticle formulation of loteprednol etabonate as a treatment for inflammation and pain in cataract surgery patients. The KPI-121 1% suspension met both primary efficacy endpoints and secondary endpoints and was well tolerated by the trial’s participants. The Waltham, Mass.-based company’s KPI-121 uses Kala’s mucus-penetrating particle technology to deliver drugs to tissues in the eye. In preclinical studies, MPP tech increased loteprednol etabonate delivery to ocular tissues 4-fold, according to the company. Get the full story a...
Source: Mass Device - May 1, 2017 Category: Medical Equipment Authors: Sarah Faulkner Tags: Clinical Trials Drug-Device Combinations Optical/Ophthalmic Pharmaceuticals Kala Pharmaceuticals Source Type: news

Crosslinking, IOLs, and Femtosecond Laser Prominent at ASCRS Crosslinking, IOLs, and Femtosecond Laser Prominent at ASCRS
The annual meeting of the American Society of Cataract and Refractive Surgery will feature new types of intraocular lens, femtosecond laser, collagen cross-linking, and microinvasive glaucoma surgery.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - April 28, 2017 Category: Consumer Health News Tags: Ophthalmology News Source Type: news

American Society of Cataract and Refractive Surgery (ASCRS) 2017 Annual Congress American Society of Cataract and Refractive Surgery (ASCRS) 2017 Annual Congress
Read clinically focused news coverage of key developments from ASCRS 2017.Medscape Ophthalmology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - April 28, 2017 Category: Consumer Health News Tags: Conference Coverage Source Type: news

Bausch & Lomb wins FDA 510(k) for Vitesse open-port vitrectomy system
Valeant Pharmaceuticals (NYSE:VRX, TSE:VRX) subsidiary Bausch & Lomb said today it won FDA 510(k) clearance for its Vitesse hypersonic open port vitrectomy system. The Bridgewater, N.J.-based company touted the newly cleared system as the 1st and only hypersonic 100% open port vitrectomy system, and said it will be exclusively available on the Stellaris Elite vision enhancement system. “I feel privileged to have been able to work with Bausch + Lomb in the development of this new technology since its birth in the lab in 2012. This is perhaps the first major technological change in the way we remove the vitreo...
Source: Mass Device - April 27, 2017 Category: Medical Equipment Authors: Fink Densford Tags: 510(k) Food & Drug Administration (FDA) Optical/Ophthalmic Regulatory/Compliance Bausch Lomb Valeant Pharmaceuticals Source Type: news

Ivantis launches 2nd IDE study of Hydrus microstent
Ivantis said today it won approval from the FDA to initiate a 2nd investigational device exemption trial of its Hydrus microstent, testing the device in patients with advanced glaucoma who are undergoing stand-alone glaucoma surgery without combined cataract surgery. The Hydrus microstent is designed for minimally invasive microsurgical procedures to reduce eye pressure in patients with glaucoma. The device is multi-modal, the company said, by creating a large opening through the trabecular meshwork and dilating and scaffolding the conventional pathway through which fluid exits the eye. In the newly approved Summit tr...
Source: Mass Device - April 25, 2017 Category: Medical Equipment Authors: Fink Densford Tags: Clinical Trials Food & Drug Administration (FDA) Optical/Ophthalmic Ivantis Source Type: news

MassDevice.com +5 | The top 5 medtech stories for April 21, 2017
Say hello to MassDevice +5, a bite-sized view of the top five medtech stories of the day. This feature of MassDevice.com’s coverage highlights our 5 biggest and most influential stories from the day’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry. Get this in your inbox everyday by subscribing to our newsletters.   5. Beaver-Visitec picks up Malosa Medical Beaver-Visitec said today it acquired U.K.-based single-use ophthalmology surgical instrument maker Malosa Medical for an undisclosed amount. Malosa Medical has a portfolio of more than 40...
Source: Mass Device - April 21, 2017 Category: Medical Equipment Authors: MassDevice Tags: News Well Plus 5 Source Type: news

Beaver-Visitec picks up Malosa Medical
Beaver-Visitec said today it acquired U.K.-based single-use ophthalmology surgical instrument maker Malosa Medical for an undisclosed amount. Malosa Medical has a portfolio of more than 400 products, according to Beaver-Visitec.  Malosa packages its sets in sterilized, single-use packs which contain all required instruments and consumables for specific ophthalmic procedures, including cataract surgery and intravitreal injections, BVI added. “We are thrilled to be joining forces with BVI and firmly believe that our combined offering of physician-preferred single-use ophthalmic instrumentation will continue t...
Source: Mass Device - April 21, 2017 Category: Medical Equipment Authors: Fink Densford Tags: Business/Financial News Mergers & Acquisitions Optical/Ophthalmic Beaver-Visitec Malosa Medical Source Type: news

Data analysis finds lower risk of infection with LASIK than with contacts over time
(University of Tennessee Health Science Center) A meta-data analysis comparing the incidence of microbial keratitis, an infection of the cornea caused by bacteria or a virus, for contact lens wearers versus post-LASIK (laser-assisted in situ keratomileusis) patients indicates that over time the infection rate for the contact lens wearers was higher than for those who had LASIK to correct their vision. An article on the findings was published in the Journal of Cataract& Refractive Surgery, a high-impact, peer-reviewed scientific journal. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - April 21, 2017 Category: Global & Universal Source Type: news

Icon Bioscience Submits NDA For Dexycu, a Potential Transformational Drug Therapy for Treating Inflammation Associated with Cataract Surgery
Sunnyvale, CA (April 13, 2017) – Icon Bioscience Inc. (IBI), a specialty biopharmaceutical company focused on utilizing its Verisome® drug-delivery platform to develop unique intraocular eye-care therapeutics, today announced the submission of a... (Source: Drugs.com - New Drug Applications)
Source: Drugs.com - New Drug Applications - April 13, 2017 Category: Drugs & Pharmacology Source Type: news

Cataract surgery: When is the laser method a good idea?
(Source: MayoClinic.com - Ask a Specialist)
Source: MayoClinic.com - Ask a Specialist - April 5, 2017 Category: Consumer Health News Source Type: news

Most patients get priority surgeries within target wait times: report
Three out of four Canadians received a hip or knee replacement, cataract surgery, hip fracture repair or cancer radiation therapy within the recommended wait times for those priority procedures, although there was often wide variation from one province to another, researchers say. (Source: CBC | Health)
Source: CBC | Health - March 28, 2017 Category: Consumer Health News Tags: News/Health Source Type: news

Substantial Variability in Myopic Shift After Intraocular Lens Implantation Substantial Variability in Myopic Shift After Intraocular Lens Implantation
Infants who undergo intraocular lens (IOL) implantation for congenital cataracts experience considerable variability in the myopic shift that accompanies the axial elongation after surgery, according to results from the Infant Aphakia Treatment Study (IATS).Reuters Health Information (Source: Medscape General Surgery Headlines)
Source: Medscape General Surgery Headlines - March 14, 2017 Category: Surgery Tags: Ophthalmology News Source Type: news

Cataract surgery: Will my vision deteriorate after cataract surgery?
(Source: MayoClinic.com - Ask a Specialist)
Source: MayoClinic.com - Ask a Specialist - March 3, 2017 Category: Consumer Health News Source Type: news

Johnson & Johnson completes acquisition of Abbott Medical Optics
Johnson & Johnson (NYSE: JNJ) has completed the acquisition of Abbott Medical Optics (AMO), a wholly-owned subsidiary of Abbott. The all-cash $4.325 billion acquisition was originally announced Sept. 16, 2016, and includes ophthalmic products in three areas of patient care: cataract surgery, laser refractive surgery and consumer eye health. (Source: World Pharma News)
Source: World Pharma News - March 1, 2017 Category: Pharmaceuticals Tags: Featured Johnson & Business and Industry Source Type: news

Johnson & Johnson adds to its eye health brand
Johnson& Johnson (NYSE: JNJ) completed the acquisition of Abbott Medical Optics, bringing together their capabilities with Johnson& Johnson Vision Care in Jacksonville. The $4.325 billion all-cash acquisition announced in September included products in three areas of care: cataract surgery, laser refractive surgery and consumer eye health. Those products will now join the Acuvue-brand contact lens business under the name Johnson& Johnson Vision. Acuvue contacts are made in Jacksonville. “With… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - February 28, 2017 Category: Biotechnology Authors: Jensen Werley Source Type: news

Johnson & Johnson adds to its eye health brand
Johnson& Johnson (NYSE: JNJ) completed the acquisition of Abbott Medical Optics, bringing together their capabilities with Johnson& Johnson Vision Care in Jacksonville. The $4.325 billion all-cash acquisition announced in September included products in three areas of care: cataract surgery, laser refractive surgery and consumer eye health. Those products will now join the Acuvue-brand contact lens business under the name Johnson& Johnson Vision. Acuvue contacts are made in Jacksonville. “With… (Source: bizjournals.com Health Care:Physician Practices headlines)
Source: bizjournals.com Health Care:Physician Practices headlines - February 28, 2017 Category: American Health Authors: Jensen Werley Source Type: news

MassDevice.com +5 | The top 5 medtech stories for February 27, 2017
Say hello to MassDevice +5, a bite-sized view of the top five medtech stories of the day. This feature of MassDevice.com’s coverage highlights our 5 biggest and most influential stories from the day’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry. Get this in your inbox everyday by subscribing to our newsletters.   5. Integra LifeSciences slides on Q4 sales miss Integra LifeSciences met the consensus earnings forecast for its 4th-quarter earnings, but saw share prices slide nevertheless after it missed Wall Street’s top-line outlook la...
Source: Mass Device - February 27, 2017 Category: Medical Equipment Authors: MassDevice Tags: Blog News Well Plus 5 Source Type: news

Johnson & Johnson Completes Acquisition of Abbott Medical Optics
Johnson& Johnson Vision will reach more patients globally with expansion into cataract surgery (Source: Johnson and Johnson)
Source: Johnson and Johnson - February 27, 2017 Category: Pharmaceuticals Source Type: news

Johnson & Johnson closes $4.3B Abbott Medical Optics buy
Johnson & Johnson (NYSE:JNJ) said today that it closed the $4.33 billion buyout of Abbott Medical Optics from Abbott (NYSE:ABT). The deal for AMO, announced in September 2016, includes its portfolio of ophthalmic products covering cataract surgery, laser refractive surgery and consumer eye health. The business posts annual sales of $1.1 billion and is slated to be folded into the medical devices segment as a separate platform within J&J Vision Care. “With the addition of AMO’s world-renowned ophthalmic surgery business, J&J Vision is poised to become a world leader in e...
Source: Mass Device - February 27, 2017 Category: Medical Equipment Authors: Brad Perriello Tags: Mergers & Acquisitions Optical/Ophthalmic Wall Street Beat Abbott Johnson & Johnson Source Type: news

Current, Effective Advantages of Femto Phaco Current, Effective Advantages of Femto Phaco
What benefits does femtosecond laser-assisted cataract surgery offer over manual phacoemulsification?Current Opinion in Ophthalmology (Source: Medscape Ophthalmology Headlines)
Source: Medscape Ophthalmology Headlines - February 23, 2017 Category: Opthalmology Tags: Ophthalmology Journal Article Source Type: news